{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:51:26Z","timestamp":1761630686570,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.ad.2013.12.023","type":"journal-article","created":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T23:30:24Z","timestamp":1398727824000},"page":"e55-e60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dermatitis por telaprevir: manejo con corticoides orales en casos refractarios"],"prefix":"10.1016","volume":"105","author":[{"given":"J.","family":"Garcias-Ladaria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"P\u00e9rez-Ferriols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ortega-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Diago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2013.12.023_bib0005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1157\/13090276","article-title":"La hepatitis C en Espa\u00f1a","volume":"127","author":"Bruguera","year":"2006","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.ad.2013.12.023_bib0010","doi-asserted-by":"crossref","first-page":"e55285","DOI":"10.1371\/journal.pone.0055285","article-title":"Eligibility and safety of triple therapy for hepatitis C: Lessons learned from the first experience in a real world setting","volume":"8","author":"Maasoumy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ad.2013.12.023_bib0015","doi-asserted-by":"crossref","first-page":"e52158","DOI":"10.1371\/journal.pone.0052158","article-title":"Efficacy and tolerability of telaprevir for chronic hepatitis virus C genotype 1 infection: A meta-analysis","volume":"7","author":"Kong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ad.2013.12.023_bib0020","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jhep.2011.08.006","article-title":"Dermatological side effects of hepatitis C and its treatment: Patient management in the era of direct-acting antivirals","volume":"56","author":"Cacoub","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.ad.2013.12.023_bib0025","unstructured":"Informe de utilidad terap\u00e9utica UT\/V1\/28022012: criterios y recomendaciones generales para el tratamiento con boceprevir y telaprevir de la hepatitis cr\u00f3nica C (VHC) en pacientes monoinfectados [consultado 28 Jun 2013]. Disponible en: http:\/\/www.msssi.gob.es\/profesionales\/farmacia\/pdf\/TRATAMIENTO_HEPATITIS_CRONICA_C.pdf"},{"key":"10.1016\/j.ad.2013.12.023_bib0030","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1001\/jamadermatol.2013.938","article-title":"Telaprevir-related dermatitis","volume":"149","author":"Roujeau","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.ad.2013.12.023_bib0035","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/liv.12080","article-title":"How to optimize HCV therapy in genotype 1 patients: Management of side-effects","volume":"33","author":"Chopra","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.ad.2013.12.023_bib0040","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ad.2013.04.009","article-title":"Toxicidad cut\u00e1nea por telaprevir: un nuevo f\u00e1rmaco que es necesario conocer","volume":"105","author":"L\u00f3pez-Villaescusa","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2013.12.023_bib0045","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/archdermatol.2012.2039","article-title":"Telaprevir-induced pityriasis rubra pilaris-like drug eruption","volume":"148","author":"Stalling","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2013.12.023_bib0050","first-page":"469","article-title":"Interacciones de los nuevos inhibidores de la proteasa para el tratamiento de la hepatitis C: telaprevir y boceprevir","volume":"36","author":"Izquierdo-Garc\u00eda","year":"2012","journal-title":"Farm Hosp"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731014001811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731014001811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:03:30Z","timestamp":1757552610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731014001811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0001731014001811"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2013.12.023","relation":{},"ISSN":["0001-7310"],"issn-type":[{"type":"print","value":"0001-7310"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dermatitis por telaprevir: manejo con corticoides orales en casos refractarios","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2013.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Espa\u00f1a, S.L.U. y AEDV. All rights reserved.","name":"copyright","label":"Copyright"}]}}